| Head and neck cancer: improving outcomes with a multidisciplinary approach C Lo Nigro, N Denaro, A Merlotti, M Merlano Cancer management and research, 363-371, 2017 | 224 | 2017 |
| Dysphagia in head and neck cancer patients: pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations N Denaro, MC Merlano, EG Russi Clinical and experimental otorhinolaryngology 6 (3), 117, 2013 | 168 | 2013 |
| Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus A Schindler, N Denaro, EG Russi, N Pizzorni, P Bossi, A Merlotti, ... Critical reviews in oncology/hematology 96 (2), 372-384, 2015 | 155 | 2015 |
| Long noncoding RNA s as regulators of cancer immunity N Denaro, MC Merlano, C Lo Nigro Molecular oncology 13 (1), 61-73, 2019 | 145 | 2019 |
| Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience N Denaro, MC Merlano, EG Russi Clinical and experimental otorhinolaryngology 9 (4), 287, 2016 | 143 | 2016 |
| Metastatic disease in head & neck oncology P Pisani, M Airoldi, A Allais, PA Valletti, M Battista, M Benazzo, R Briatore, ... Acta Otorhinolaryngologica Italica 40 (Suppl 1), S1, 2020 | 112 | 2020 |
| State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013 N Denaro, EG Russi, V Adamo, MC Merlano Oncology 86 (4), 212-229, 2014 | 102 | 2014 |
| A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell … P Bossi, R Miceli, LD Locati, D Ferrari, S Vecchio, G Moretti, N Denaro, ... Annals of Oncology 28 (11), 2820-2826, 2017 | 77 | 2017 |
| Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus EG Russi, F Moretto, M Rampino, M Benasso, A Bacigalupo, V De Sanctis, ... Critical Reviews in Oncology/Hematology 96 (1), 167-182, 2015 | 66 | 2015 |
| A systematic review of current and emerging approaches in the field of larynx preservation N Denaro, EG Russi, JL Lefebvre, MC Merlano Radiotherapy and oncology 110 (1), 16-24, 2014 | 66 | 2014 |
| The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer N Denaro, CL Nigro, EG Russi, MC Merlano OncoTargets and therapy, 1231-1241, 2013 | 66 | 2013 |
| Impact of age on acute toxicity induced by bio-or chemo-radiotherapy in patients with head and neck cancer MC Merlano, M Monteverde, I Colantonio, N Denaro, CL Nigro, G Natoli, ... Oral oncology 48 (10), 1051-1057, 2012 | 62 | 2012 |
| Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with … L Lattanzio, N Denaro, D Vivenza, C Varamo, G Strola, M Fortunato, ... Cancer Immunology, Immunotherapy 66, 573-579, 2017 | 58 | 2017 |
| Cancer and stress: what’s matter? from epidemiology: the psychologist and oncologist point of view N Denaro, L Tomasello, EG Russi J Cancer Ther Res 3 (6), 10.7243, 2014 | 51 | 2014 |
| Pros and cons of the new edition of TNM classification of head and neck squamous cell carcinoma N Denaro, EG Russi, MC Merlano Oncology 95 (4), 202-210, 2018 | 45 | 2018 |
| Sepsis in head and neck cancer patients treated with chemotherapy and radiation: literature review and consensus A Mirabile, G Numico, EG Russi, P Bossi, F Crippa, A Bacigalupo, ... Critical reviews in oncology/hematology 95 (2), 191-213, 2015 | 45 | 2015 |
| The role of p53 and MDM2 in head and neck cancer N Denaro, C Lo Nigro, G Natoli, EG Russi, V Adamo, MC Merlano International Scholarly Research Notices 2011, 2011 | 40 | 2011 |
| Strategies for non-resectable head and neck cancer N Denaro, EG Russi, MC Merlano Current treatment options in oncology 14, 492-504, 2013 | 32 | 2013 |
| Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective N Denaro, MC Merlano, EG Russi, CL Nigro Anticancer research 34 (12), 6887-6896, 2014 | 31 | 2014 |
| Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions N Denaro, EG Russi, V Adamo, I Colantonio, MC Merlano Oncology 81 (1), 21-29, 2011 | 24 | 2011 |
Marco MerlanoCandiolo cancer institute, FPO - Candiolo (Turin) ItalyEmail verificata su ircc.it
